FUNI · Hypha Labs, Inc.
$0.01
+0.00 (+3.33%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, our balance of cash on hand was $5,110, and we had negative working capital of $1,577,350 and an accumulated deficit of $24,996,836 resulting from recurring losses. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.52M
Shares
163.90M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W close$0.01–0.04
Avg vol 30d197K
Short int55K · 0.0% float · 1.0d
Short vol36%
DataJan 2020–Aug 2026
Filing10-Q · Aug 14
Up next
FQ4-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−62%
below
Price vs 50-day avg
−34%
below
RSI (14)
38
neutral
MACD trend
Negative
52-week position
7%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−44%
trailing
6-month return
−72%
trailing
YTD return
−77%
this year
Relative strength
−85%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +8.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
36
low risk · 0–100
Fundamentals
Revenue growth
+132%
Y/Y
Gross margin
56%
contracting
EPS growth
−100%
Y/Y
Free cash flow
$-412.9K
Quant / Vol
risk profile
Volatility
173%
annualized · 1-yr
Max drawdown
−82%
past year
ATR
30.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−62%
Bearish
Price vs 50-day avg
−34%
Bearish
RSI (14)
38
Neutral
MACD trend
Negative
Bearish
52-week position
7%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +8.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 7%
Range high $0
vs 200-day avg -62%
vs 50-day avg -34%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FUNI
this stock
Hypha Labs, Inc.
|
$1.52M | -76.8% | +131.9% | — | 0.0% |
|
TMO
Thermo Fisher Scientific Inc.
|
$230.05B | +7.4% | +14.5% | 33.5 | 1.3% |
|
DHR
Danaher Corp /De/
|
$151.89B | -5.6% | +8.5% | 38.3 | 1.2% |
|
NTRA
Natera, Inc.
|
$48.82B | +42.4% | -2.8% | — | 3.0% |
|
IQV
Iqvia Holdings Inc.
|
$43.79B | +16.1% | +41.6% | 32.6 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FUNI | +3.3% | -44.0% | -71.8% | -50.3% | -76.8% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +2.9% | -47.0% | -85.3% | -53.3% | -89.6% |